Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.
Publication
, Journal Article
Stout, JE; Lai, JC; Giner, J; Hamilton, CD
Published in: Clin Infect Dis
August 15, 2002
We report a case of retinal toxoplasmosis that occurred in a patient with acquired immunodeficiency syndrome who had a previous diagnosis of cerebral toxoplasmosis, despite the patient having had a robust immune response to highly active antiretroviral therapy. Clinical decisions about whether to discontinue secondary prophylaxis for opportunistic infections continue to be challenging.
Duke Scholars
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
August 15, 2002
Volume
35
Issue
4
Start / End Page
e37 / e39
Location
United States
Related Subject Headings
- Toxoplasmosis
- Retinal Diseases
- Microbiology
- Male
- Humans
- HIV Infections
- Antiretroviral Therapy, Highly Active
- Adult
- AIDS-Related Opportunistic Infections
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Stout, J. E., Lai, J. C., Giner, J., & Hamilton, C. D. (2002). Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy. Clin Infect Dis, 35(4), e37–e39. https://doi.org/10.1086/341306
Stout, Jason E., James C. Lai, Julia Giner, and Carol Dukes Hamilton. “Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.” Clin Infect Dis 35, no. 4 (August 15, 2002): e37–39. https://doi.org/10.1086/341306.
Stout JE, Lai JC, Giner J, Hamilton CD. Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy. Clin Infect Dis. 2002 Aug 15;35(4):e37–9.
Stout, Jason E., et al. “Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.” Clin Infect Dis, vol. 35, no. 4, Aug. 2002, pp. e37–39. Pubmed, doi:10.1086/341306.
Stout JE, Lai JC, Giner J, Hamilton CD. Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy. Clin Infect Dis. 2002 Aug 15;35(4):e37–e39.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
August 15, 2002
Volume
35
Issue
4
Start / End Page
e37 / e39
Location
United States
Related Subject Headings
- Toxoplasmosis
- Retinal Diseases
- Microbiology
- Male
- Humans
- HIV Infections
- Antiretroviral Therapy, Highly Active
- Adult
- AIDS-Related Opportunistic Infections
- 3202 Clinical sciences